marijuana stocks

Form 8-K for LEXARIA CORP.


24-Aug-2015

Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure.A copy of the news release announcing the Company’s technology achieves Cannabidiol absorption rate 499% greater than baseline in laboratory testing filed as exhibit 99.1 to this current report and is hereby incorporated by reference.

 


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Cara Therapeutics, Inc. (CARA) Announces Participation in 2018 Spring Clinical Meetings of the National Kidney Foundation

Cara Therapeutics Announces Participation in 2018 Spring Clinical Meetings of the National…

Organigram Holdings Inc. (OGI) to Report First Quarter Fiscal 2022 Results on January 11, 2022

Organigram to Report First Quarter Fiscal 2022 Results on January 11, 2022…

$GBLX Announces Deployment of Commercial Units

GrowBLOX Announces Deployment of Commercial Units Cannabis Cultivation Technology Arrives in Puerto…